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OBJECTIVE
To summarize the evidence on effectiveness of translational diabetes prevention
programs, based on promoting lifestyle change to prevent type 2 diabetes in real-
world settings and to examine whether adherence to international guideline
recommendations is associated with effectiveness.
RESEARCH DESIGN AND METHODS
Bibliographic databases were searched up to July 2012. Included studies had a
follow-up of ‡12 months and outcomes comparing change in body composition,
glycemic control, or progression to diabetes. Lifestyle interventions aimed to
translate evidence from previous efﬁcacy trials of diabetes prevention into real-
world intervention programs. Data were combined using random-effects meta-
analysis and meta-regression considering the relationship between intervention
effectiveness and adherence to guidelines.
RESULTS
Twenty-ﬁve studiesmet the inclusion criteria. The primarymeta-analysis included
22 studies (24 study groups) with outcome data for weight loss at 12 months. The
pooled result of the direct pairwise meta-analysis shows that lifestyle interven-
tions resulted in ameanweight loss of 2.12 kg (95% CI22.61 to21.63; I2 = 91.4%).
Adherence to guidelines was signiﬁcantly associatedwith a greater weight loss (an
increase of 0.3 kg per point increase on a 12-point guideline-adherence scale).
CONCLUSIONS
Evidence suggests that pragmatic diabetes prevention programs are effective.
Effectiveness varies substantially between programs but can be improved by
maximizing guideline adherence. However, more research is needed to establish
optimal strategies for maximizing both cost-effectiveness and longer-term main-
tenance of weight loss and diabetes prevention effects.
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A major opportunity exists to drasti-
cally reduce the incidence of type 2
diabetes, a disease that has a huge im-
pact on patients and health care sys-
tems worldwide. Large, high-quality
clinical trials (1–3) show that relatively
modest changes in diet and physical
activity reduce the incidence of type 2
diabetes by .50% for people with im-
paired glucose regulation. Impaired
glucose regulation is an intermediate
condition between normal glucose reg-
ulation and type 2 diabetes, which con-
fers an increased risk of progression to
type 2 diabetes (4). Indeed, within-trial
data show that the rate of progression
to type 2 diabetes at 7 years of follow-up
was reduced to almost zero for people
who had succeeded in making ﬁve mod-
est lifestyle changes (2). The main driv-
ers of diabetes prevention appear to be
weight loss and physical activity (5,6).
However, a substantial challenge re-
mains in translating these ﬁndings into
routine clinical practice. The intensive
and prohibitively expensive interven-
tions used in clinical trials, to ensure life-
style change, need to be translated into
practical affordable interventions that
are deliverable in real-world health
care systems and which, nevertheless,
retain a reasonable degree of effective-
ness (7).
Since the publication of the original
diabetes prevention clinical trials be-
tween 1996 and 2001, a number of
translational or “real-world” diabetes
prevention programs (8,9) have aimed
to translate the evidence (1,10–12). A
meta-analysis of the evidence on trans-
lational interventions was published in
2010 (9), although this review excluded
15 studies that were conducted in non–
health care settings. A more recent
meta-analysis was published in 2012
(13). However, the authors only focused
on translation of evidence from the U.S.
Diabetes Prevention Program and also
included studies where up to half of
the population already had diabetes.
Other systematic reviews of diabetes
prevention interventions have either
not included a meta-analysis (6,8,14–
17) or have not focused on translational
studies (3,6,15,16,18–22). Overall, the
systematic reviews conducted to date
indicate that real-world diabetes pre-
vention programs vary widely in their
effectiveness, although most produce
lower levels of weight loss than the
more intensive interventions used in
the clinical efﬁcacy trials (9). Explaining
this variation is important. If we can
identify the components of lifestyle in-
terventions that are reliably associated
with increased effectiveness, this will
inform the design of more efﬁcient
(cost-effective) diabetes prevention
programs.
Recently published evidence-based
guidelines (23,24) make distinct recom-
mendations about which intervention
components should be included to max-
imize the effectiveness of lifestyle inter-
ventions for diabetes prevention. Such
recommendations include the use of
group-based interventions to minimize
cost and the use of speciﬁc behavior-
change strategies that are associated
with increased effectiveness. These rec-
ommendations come from systematic
reviews of the wider literature on sup-
porting changes in diet and physical ac-
tivity in a range of populations (25,26).
Lifestyle interventions for diabetes pre-
vention vary in their content; however,
whether closer adherence to the guide-
line recommendations might improve
the performance of real-world diabetes
prevention interventions remains un-
clear. To consolidate the evidence, we
undertook a systematic review of stud-
ies considering the effectiveness of
translational interventions for preven-
tion of type 2 diabetes in high-risk
populations. The primary aim was to con-
duct a meta-analysis of the effectiveness
of pragmatic interventions on weight
loss and conduct a meta-regression to
examine whether closer adherence to
guideline recommendations for diabetes
prevention improves the effectiveness of
real-world interventions. If sufﬁcient data
were available, a secondary aim was to
consider other diabetes risk factors using
similar methods.
RESEARCH DESIGN AND METHODS
Search Strategy and Study Selection
We included experimental and observa-
tional studies that considered the effec-
tiveness of a lifestyle intervention (diet
or exercise) alone or compared with
control, where the stated aim of the in-
tervention was diabetes risk reduction
or prevention of type 2 diabetes, and
where the focus of the study was to
translate evidence from previous diabe-
tes efﬁcacy trials into routine health
care or a community setting. For studies
to be eligible for inclusion, we required
them to include adults ($18 years old)
identiﬁed as being at high risk of devel-
oping type 2 diabetes (for example,
obese, sedentary lifestyle, family history
of diabetes, older age, metabolic syn-
drome, impaired glucose regulation,
prediabetes, or elevated diabetes risk
score) (24), have a minimum follow-up
of 52 weeks, and have an outcome re-
lating to diabetes risk, as measured by a
change in body composition or a change
in glycemic control or report progres-
sion to diabetes (incidence or preva-
lence). The focus of the review was
primary prevention; therefore, we ex-
cluded trials where .10% of the popu-
lation had established diabetes. We
included only studies published in the
English language and as full-length
articles.
We searched Embase, MEDLINE, and
the Cochrane Library (Issue 7, 2012),
using a combination of MeSH terms
and keywords that were tailored to in-
dividual bibliographic databases. We re-
stricted searches to articles published
after January 1998; the starting point
of 1998 was chosen to facilitate the
identiﬁcation of studies that were in-
formed by or translating evidence from
previous diabetes prevention efﬁcacy
trials (1,10–12). In order to avoid miss-
ing papers, the ﬁnal search strategy in-
cluded only terms related to the
intervention and the study design. An
example search strategy (MEDLINE) is
outlined in Supplementary Table 1.
We combined the results of an initial
search and an updated supplementary
search, which together identiﬁed papers
up to the end of July 2012.
Two reviewers independently as-
sessed abstracts and titles for eligibility
and retrieved potentially relevant ar-
ticles, with differences resolved by a
third reviewer where necessary. Where
studies appeared to meet all the inclu-
sion criteria but data were incomplete,
we contacted authors for additional
data or clariﬁcation. In an attempt to
identify further papers not identiﬁed
through electronic searching, we exam-
ined the reference lists of included pa-
pers and relevant reviews.
Data Extraction and Quality
Assessment
Data were extracted by one reviewer,
and a second reviewer subsequently
care.diabetesjournals.org Dunkley and Associates 923
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checked for consistency. We extracted
data on sample size, population demo-
graphics, intervention details, and length
of follow-up. Where available, we re-
corded outcome data for the mean
change from baseline to 12 months’
follow-up for the following outcomes:
weight, BMI, waist circumference, fasting
glucose, 2-h glucose, glycated hemo-
globin (HbA1c), total cholesterol, LDL cho-
lesterol, HDL cholesterol, triglycerides,
systolic blood pressure (BP), and diastolic
BP. Incidence of type 2 diabetes was
also recorded. We retrieved all papers
relating to a particular study, including
those on design and methodology (if
reported separately), and any Supple-
mentary Data.
We assessed the quality of selected
studies according to the U.K.’s National
Institute for Health and Clinical Excel-
lence (NICE) quality appraisal checklist
for quantitative intervention studies
(27). The checklist includes criteria for
assessing the internal and external val-
idity of experimental and observational
quantitative studies (randomized con-
trolled trials [RCTs], nonrandomized con-
trolled trials, and before and after
studies) and allows assignment of an over-
all quality grade (categories ++, +, or2).
Coding of Intervention Content
We coded intervention content (Supple-
mentary Tables 1 and 3) in relation to
the recommendations for lifestyle inter-
ventions for the prevention of diabetes
provided by both the IMAGE project
(Development and Implementation
of a European Guideline and Training
Standards for Diabetes prevention)
(23) and NICE (24). Where a study inter-
vention was inadequately described, we
requested further details from the au-
thors. If available information was insuf-
ﬁcient to allow coding, we coded data as
missing; where an intervention ap-
peared to be well described but a par-
ticular component (e.g., engaging social
support) was not mentioned or could
not be implied from other text, we as-
sumed that the component was not
used. In the analysis, we assumed that
missing values indicated that the guide-
line criterion was not met.
Data Synthesis and Analysis
We converted all values reported in im-
perial units into metric units. Capillary
blood glucose values were converted
to plasma equivalent values (28). If stud-
ies did not directly report the mean SD,
for change from baseline to 12 months
for the outcomes of interest, they were
calculated. We calculated the mean
change by subtracting the baseline
mean value from the mean at 12
months. We calculated the SD from re-
ported P values or CI, as recommended
by the Cochrane Collaboration (29).
Where data were insufﬁcient, to allow
calculation of the SD, we imputed values
for each outcome based on the correla-
tion estimates from those studies that
reported; for weight, the correlation
used in these imputations was 0.95
(30–34).
For the primary outcome of interest
(weight), we conducted direct-pairwise
comparison meta-analyses to examine
the effect size (change from baseline
to 12 months) where data were avail-
able. Only intervention arms were in-
cluded in the meta-analysis. This was
because we were interested in whether
adherence to guidelines improved
weight loss; therefore, only arms in
which people received an intervention
were applicable. Meta-regression was
used to assess the relationship between
weight change at 12 months and the
total IMAGE guidance score and the to-
tal NICE guidance score, as explanatory
variables, in separate univariate analy-
ses. We performed further metaregres-
sion with the individual guideline
components as the explanatory varia-
bles where at least three studies fell
into each category. We conducted sim-
ilar analyses for the secondary out-
comes of interest; however, as these
outcomes were reported in fewer
studies and to avoid multiple testing,
metaregression of individual guideline
components against secondary out-
comes was not performed. We per-
formed sensitivity analyses for the
primary outcome, weight, where miss-
ing guideline data were treated as un-
known and a total guidance score
was not given for those studies and
where we restricted the analysis to
RCTs only.
We assessed publication bias using the
Egger test and heterogeneity using the I2
statistic. Due to high levels of heteroge-
neity, we used random-effects models
throughout to calculate effect sizes. We
performed all analyses in Stata version
12.1 (StataCorp, College Station, TX).
RESULTS
Identiﬁcation of Studies
Results relating to identiﬁcation and se-
lection of eligible trials are summarized
in Fig. 1. Searches yielded 6,326 cita-
tions, and 3,872 unique titles or ab-
stracts were screened for eligibility.
After full text retrieval of 114 potentially
relevant papers, 20 additional papers
were identiﬁed from reference lists,
making a total of 134. Authors for 13
studies were then contacted in order
to clarify eligibility criteria or for addi-
tional outcome data. Replies were re-
ceived for 12 studies, 10 of which were
subsequently included in the 25 studies
(30–54) (35 articles [30–64]) that met
the review criteria.
Summary of Included Studies
The 25 studies (30–54) included in the
systematic review are summarized in
Table 1. Study interventions included ei-
ther dietary intervention or physical ac-
tivity intervention or both. Standard/
brief advice on diet and/or exercise
was considered to be comparable with
usual care and not judged to be an active
intervention. One study focused solely
on the effectiveness of physical activity
intervention (54), 1 combined dietary
intervention and a supervised exercise
program (44), and 23 considered the ef-
fectiveness of combined dietary and
physical activity intervention. Eleven of
the studies were RCTs, 11 were before
and after studies, and the remaining
studies included a matched cohort, a
prospective cohort, and a nonrandom-
ized controlled trial. All papers were
published within the last 10 years.
Studies were conducted in the U.S.
(n = 11), Australia (n = 2), Europe (n =
11), and Japan (n = 1); however, ethnic-
ity was poorly reported. The number of
people who were enrolled into the in-
tervention arm in individual studies
ranged from 8 to .2,700, with 22 stud-
ies including at least 50 participants. The
criteria used, alone or in combination, to
identify high risk included elevated BMI;
elevated diabetes risk score (Finnish Di-
abetes Risk Score [FINDRISC] [65],
American Diabetes Association [ADA]
[66]); raised random, fasting, or 2-h glu-
cose (ﬁnger prick or venous sample);
older age; ethnicity; family history of
diabetes; and previous medical history
of cardiovascular disease, polycystic
ovary syndrome, gestational diabetes
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mellitus, metabolic syndrome, or ele-
vated BP or lipids. Length of follow-up
ranged from12months to;4 years. The
mean age and BMI of participants
ranged from 38 to 65 years and 25 to
37 kg/m2, respectively, and the propor-
tion of males ranged from 7 to 66%.
Outcome data for change in weight
were available for 24 of 25 studies (not
Costa [39]); 22 of 25 studies reported
weight at 12 months (Supplementary
Table 4). Additional 12-month data re-
ported for 23 studies (Supplementary Ta-
bles 1 and 5) included change in BMI (18
studies), waist size (16), fasting glucose
(15), 2-h glucose (10) HbA1c (7), total cho-
lesterol (13), LDL (7), HDL (12), triglycer-
ides (10), systolic BP (13), diastolic BP
(11), and the incidence of diabetes after
12 months (8). Outcome data for change
in physical activity and diet were poorly
reported. Overall, considerable hetero-
geneity was evident between studies in
relation to several key characteristics
including the setting, population, crite-
ria used to identify diabetes risk, inter-
ventions, and follow-up.
Study Quality
A breakdown of study quality is pre-
sented in Supplementary Table 6. Most
studies achieved a high-quality grading
for internal validity (19 of 25). However,
details relating to the source/eligible
population and area and the selected
participants were less well reported;
only 11 studies achieved a high-quality
score for external validity.
Scoring of Intervention Content
Details of coding scores for study inter-
ventions are presented in Supplemen-
tary Table 3. Fourteen of the 25
intervention groups included in the
main meta-analysis attained an overall
score of $9 out of a possible 12 in re-
lation to meeting NICE guideline recom-
mendations; 19 scored $7. For IMAGE
guideline recommendations, an overall
score of $5 out of a possible 6 was
achieved by 12 study groups.
Meta-analysis
Twenty-two studies involving 5,500 par-
ticipants (estimated 43% male) were in-
cluded in the meta-analysis for mean
weight change at 12 months. One study
was excluded from the primary meta-
analysis, as weight change was not re-
corded as a study outcome (39), and two
studies were excluded from all analyses,
as they only reported 18-month data
(45,53). Two studies included in the
meta-analysis had two intervention
arms (43,54), meaning that 24 study
groups were analyzed.
The pooled result of thedirect-pairwise
meta-analysis (Fig. 2) shows that lifestyle
interventions resulted in a mean weight
loss of 2.12 kg (95% CI 22.61 to 21.63;
I2 = 91.4%). Supplementary Figs. 1 and 2
show the metaregression results for the
NICE and IMAGE guidelines for weight,
respectively. Greater adherence to guide-
line recommendations was signiﬁcantly
associated with greater weight loss for
both sets of guidelines (Table 2). Adher-
ence to individual guideline elements also
tended to result in greater weight loss,
some of which were statistically signiﬁ-
cant (Table 2). Sensitivity analyses with-
out imputed data are also shown in Table
2. This showed that, where data were
complete, the effect sizes were generally
larger for bothNICE and IMAGE guidance:
20.39 kg per point increase on the 12-
point adherence scale (95% CI 20.73 to
20.06) and 20.59 kg per point increase
on the 6-point adherence scale (95% CI
21.00 to20.19) respectively.
None of the study level covariates
(proportion of males, mean age, propor-
tion of white European ethnicity) were
signiﬁcantly associated with the mean
Figure 1—Flowchart of selection of studies from search to ﬁnal inclusion. DM, diabetes mellitus; T2DM, type 2 diabetes mellitus.
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difference in weight change. Sensitivity
analysis, restricted to RCTs only, indi-
cated a mean weight change (22.3 kg
[95% CI 23.2 to 21.4) that is similar to
the overall result. Additional analysis
comparing the difference in weight lost
between the treatment and control
arms, for RCTs only, suggests that on
average the intervention arm lost an
extra 21.62 kg (95% CI22.37 to20.86;
P , 0.01). Furthermore, sensitivity anal-
yses that included studies scoring ++ for
external validity demonstrated a slightly
greater weight loss in higher-quality
studies (22.5 kg [95% CI 23.5 to
Table 2—Meta-regression results for weight change from baseline to 12 months
Explanatory variable No. of studies No. of participants Effect (95% CI), kg P
NICE (continuous) 24 5,500 20.29 (20.50 to 20.07) 0.012
NICE without imputation (continuous) 17 4,885 20.39 (20.73 to 20.06) 0.024
IMAGE (continuous) 24 5,500 20.43 (20.75 to 20.10) 0.012
IMAGE without imputation (continuous) 18 4,942 20.59 (21.00 to 20.19) 0.007
IMAGE B (continuous) 24 5,500 20.47 (20.78 to 20.16) 0.005
IMAGE B without imputation (continuous) 18 4,942 20.61 (20.99 to 20.23) 0.004
Engage social support (yes vs. no) 24 5,500 21.15 (22.38 to 0.07) 0.064
No. of contacts (frequency) 23 5,417 20.04 (20.08 to 0.01) 0.093
Contact time (h) 23 5,147 20.08 (20.15 to 20.02) 0.011
$16 h of contact time (yes vs. no) 23 5,147 21.65 (22.80 to 20.49) 0.007
Self-regulatory techniques (yes vs. no) 24 5,500 20.94 (22.40 to 0.52) 0.196
Empathy-building approach (yes vs. no) 24 5,500 0.48 (20.80 to 1.76) 0.445
Spread sessions over 9–18 months (yes vs. no) 24 5,500 21.25 (22.40 to 20.09) 0.035
Motivation (yes vs. no) 24 5,500 21.17 (22.42 to 0.07) 0.064
Gradual building of conﬁdence (yes vs. no) 24 5,500 20.28 (21.62 to 1.05) 0.664
Fidelity (yes vs. no) 24 5,500 20.11 (21.59 to 1.36) 0.875
Additional physical activity sessions (yes vs. no) 24 5,500 20.77 (22.41 to 0.86) 0.338
Figure 2—Forest plot showingmeanweight change in each study and the overall pooled estimate. Boxes and horizontal lines representmean weight
change and 95% CI for each study. Size of box is proportional to weight of that study result. Diamonds represent the 95% CI for pooled estimates of
effect and are centered on pooled mean weight change. PREPARE, Pre-diabetes Risk Education and Physical Activity Recommendation and
Encouragement.
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21.5]). Additionally, there was no evi-
dence of publication bias (P = 0.160,
Egger test).
All other outcomes showed an im-
provement at 12 months (Supplemen-
tary Table 7), but not all of these
reached statistical signiﬁcance. Supple-
mentary Table 8 shows the effect of ad-
herence to NICE and IMAGE guidelines
on the other outcomes. For both NICE and
IMAGE guidelines, respectively, greater
adherence resulted in better outcomes
for waist circumference (20.52 cm, P =
0.007; 20.80 cm, P = 0.001) and tri-
glycerides (20.03 mmol/L, P = 0.016;
20.04 mmol/L, 0.023). For BMI, the im-
provements were only signiﬁcant for ad-
herence to NICE guidelines (20.12 kg/m2,
P = 0.028). There was no effect on any of
the other outcomes. Across the eight
studies that reported incident diabetes,
the pooled incidence rate was 34 cases
per 1,000 person-years (95% CI 22–56),
which gives the number needed to treat
as 29.
CONCLUSIONS
The 22 translational diabetes preven-
tion programs included in our meta-
analysis signiﬁcantly reduced weight in
their intervention arms by amean 2.1 kg
at 12 months of follow up. Where data
were available, we found signiﬁcant re-
ductions in other diabetes and cardio-
vascular risk factors, including blood
glucose, BP, and some cholesterol
measures. Adherence to guideline rec-
ommendations on intervention content
and delivery was signiﬁcantly associated
with a greater weight loss such that, for
each 1-point increase on the 12-point
scale for adherence to NICE recommen-
dations an additional 0.3 kg (P = 0.012)
of weight loss was achieved; further-
more, for waist size a signiﬁcant reduc-
tion of 0.5 cm was achieved for each
point increase. The pooled diabetes in-
cidence rate was 34/1,000 person-years
(number needed to treat: 29). Outcome
data on changes in the key lifestyle be-
havior targets (physical activity and diet)
were poorly reported.
Relationship With Other Literature
The mean level of weight loss achieved
was approximately one-half to one-third
of the levels reported at the same time
point within the intervention arms of
clinical efﬁcacy trials such as the U.S.
Diabetes Prevention Program [DPP]
(;6.7 kg) and the Finnish Diabetes Pre-
vention Study [DPS] (;4.2 kg) (1,10).
This is consistent with the ﬁndings of a
meta-analytic systematic review pub-
lished in 2010 by Cardona-Morrell
et al. (9), which identiﬁed a mean net
weight loss after 12 months of 1.82 kg
(95% CI 22.7 to 20.99). Cardona-
Morrell et al. interpreted the lower level
of weight loss and a lack of signiﬁcant
differences in fasting plasma glucose
and 2-h glucose as meaning that the in-
terventions “appear to be of limited
clinical beneﬁt.” Our view is that, de-
spite the drop-off in intervention effec-
tiveness in translational studies, the
level of weight loss found in our analysis
is still likely to have a clinically meaning-
ful effect on diabetes incidence. This is
based on data from the U.S. DPP study,
which show that each kilogram of mean
weight loss is associated with a reduc-
tion of;16% in future diabetes incidence
(5). Furthermore, a recent meta-analysis,
which included studies without an in-
tervention in order to look at natural di-
abetes progression rates in high-risk
individuals, found progression rates to
diabetes from impaired fasting glucose,
impaired glucose tolerance, and both
were 47, 56, and 76 per 1,000 person-
years, respectively (67). The rate of 34
per 1,000 person-years that we found
suggests that the real-world lifestyle in-
terventions studied here did lower dia-
betes progression rates.
For our review, the mean proportion
of weight lost at 12 months’ follow-up
was 22.4%. This amount was slightly
lower than was demonstrated by a re-
cent meta-analysis conducted by Ali
et al. (13), which considered transla-
tional studies aimed at populations
with existing diabetes (#50%) or at
high future risk. They found a mean
weight loss of 24.1% (95% CI 25.9 to
22.4) after at least 9 months of follow-
up (13). This difference may in part be
due to a lower mean BMI at baseline
for studies included in our review,
compared with the Ali et al. review
(range 25–36 kg/m2 and 31–40 kg/m2,
respectively) and a slightly longer
follow-up period (12 months vs. $9).
Additionally, their review focused on
interventions based only on the U.S.
DPP, where we considered a broader
set of interventions.
Changes in the four key dietary and
physical activity targets (#30% energy
from fat, #10% energy from saturated
fat, ﬁber $15 g/1,000 kcal, $30 min
moderate physical activity daily) have
also been shown to have independent
effects on diabetes risk reduction, irre-
spective of weight loss (5). However,
few of the studies that we examined
provided data on dietary intake or phys-
ical activity, so we cannot be sure
whether diabetes prevention in these
studies is driven by increased physical
activity, dietary change, or both.
The strong association between in-
creased weight loss and increased ad-
herence to guideline recommendations
is of particular interest.Where complete
data were available, the correlation coef-
ﬁcients were larger: 20.39 kg per point
increase (95% CI20.73 to20.06) for ad-
herence to NICE guidance on a 12-point
scale and 20.59 kg per point increase
(95% CI 21.00 to 20.19) for adherence
to IMAGE guidance on a 6-point scale.
This may reﬂect a reduction in the statis-
tical noise caused by missing data, or it
may reﬂect the fact that studies that
had a stronger behavioral science input
were more likely to report the interven-
tion content in detail (andwere alsomore
likely to be effective). Overall, these data
suggest that a high proportion of the var-
iation inweight loss could be explainedby
variations in intervention design. The im-
plication is that a design based on guide-
line recommendations should lead to
performance at the higher end of the
range ($4 kg).
Strengths and Limitations
This study is novel in that it provides an
updated meta-analysis of a global set of
lifestyle interventions for diabetes pre-
vention. Our study used comprehensive
search criteria and focused on establish-
ing the utility of pragmatic attempts to
achieve diabetes prevention in real-
world service delivery settings. It also
provides novel data that appear to vali-
date the usefulness of recent guideline-
based recommendations on the content
of lifestyle interventions for diabetes
prevention.
The study is limited in that there were
insufﬁcient data to analyze outcomes
beyond 12 months; our ﬁndings may not
translate into long-term therapeutic value
due to uncertainty around sustaining
outcomes, such as weight loss, in the
longer term (68). Furthermore, results in
individual studies were not always
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reported on an intention-to-treat basis,
leading to a likely overestimation of effect
sizes. Assuming no change in weight for
those with missing data, sensitivity anal-
yses that we conducted suggest that
weight loss could be up to 0.5 kg less in
practice than the ﬁgures reported in the
studies.
Due to the nature of pragmatic imple-
mentation studies, which include a
number of uncontrolled studies, our
analysis was restricted to intervention
arms only; however, sensitivity analysis,
restricted to RCTs only, indicated a
mean weight change (22.3 kg [95% CI
23.2 to21.4) that is similar to the over-
all result. These ﬁndings suggest that
the estimate based on intervention
arms only is likely to be robust.
Implications for Practice
Our review suggests that pragmatic life-
style interventions are effective at pro-
moting weight loss and could potentially
lead to a reduced risk of developing
diabetes and cardiovascular disease in
the future. However, the difﬁculties in
translating this evidence into practice
and in delivering guideline-based in-
terventions need to be overcome. The
ability to implement these ﬁndings in
practice may be further hampered by a
lack of resource for service provision, the
design of efﬁcient risk identiﬁcation sys-
tems, and engagement of politicians and
health care organizations in funding na-
tional diabetes prevention programs;
diabetes prevention strategies require
substantial up-front investment to accrue
longer-term beneﬁts (7).
Future Directions
More research is needed to examine
the longer-term effectiveness and
cost-effectiveness of pragmatic lifestyle
interventions for diabetes prevention,
including diabetes incidence as well as
weight loss outcomes. The practical
value of diabetes prevention interven-
tions would be much clearer if we had
data on longer-term outcomes. Re-
search is also needed to identify the
role of different types of physical activ-
ity and dietary changes (6,69) and on
ways to increase effectiveness without
increasing cost. Possible approaches
might include the use of larger group sizes
and substitution or supplementation
of intervention techniques using self-
delivered formats (e.g., Internet, smart
phone, or workbook) (70).
Summary
Overall, the interventions were effec-
tive, but there was wide variation in
effectiveness. Adherence to interna-
tional guidelines on intervention con-
tent and delivery explained much of
the variance in effectiveness, implying
that effectiveness could be improved
by maximizing guideline adherence.
However, more research is needed to
establish optimal strategies for maxi-
mizing both cost-effectiveness and
longer-term maintenance of the life-
style changes that these programs can
achieve.
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